Medeonföretag

Dianovator

Dianovator AB is a start-up in diabetes technology. They develop a patient-specific decision support system for improved glycemic control by optimized insulin dosing. Their target audience is patients receiving insulin therapy using insulin pens or insulin pumps. Many of these patients experience difficulties optimizing their therapy, resulting in reduced life quality and a shorter life expectancy. Their product can help people achieve a better control, thereby reducing anxiety and lowering the risk of short and long term complications associated with poor glycemic control. Their system relies on established proven sensor technology already available on the market.

ADRESS
Dianovator AB
Medeon Science Park 
SE- 205 12  Malmö 

KONTAKT
Fredrik Ståhl, CEO
Mobil: +46 736 26 18 85
E-post: fredrik.stahl@dianovator.com

Webbsida: http://www.dianovator.se/

Medeon är en viktig life science-nod med sin centrala placering och specifika nätverk som erbjuder en av Öresundsregionens bästa tillväxtmiljöer för företagande och främjar utbytet mellan akademi, det offentliga och näringslivet.

Catrine Pauckstadt
Communications Manager